Jennifer L Gibbs, D.D.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dental Pulp | 14 | 2023 | 84 | 5.930 |
Why?
|
Apexification | 9 | 2024 | 16 | 3.150 |
Why?
|
Pulpitis | 4 | 2023 | 29 | 2.530 |
Why?
|
Calcitonin Gene-Related Peptide | 9 | 2023 | 323 | 2.400 |
Why?
|
Toothache | 4 | 2019 | 31 | 1.790 |
Why?
|
Root Canal Therapy | 6 | 2024 | 66 | 1.660 |
Why?
|
Tooth Apex | 8 | 2021 | 28 | 1.460 |
Why?
|
Trigeminal Ganglion | 6 | 2021 | 190 | 1.340 |
Why?
|
Periapical Periodontitis | 4 | 2023 | 28 | 1.110 |
Why?
|
Receptors, Neuropeptide Y | 4 | 2008 | 47 | 1.080 |
Why?
|
Facial Pain | 3 | 2022 | 120 | 1.060 |
Why?
|
Molar | 3 | 2022 | 156 | 0.990 |
Why?
|
Root Resorption | 1 | 2024 | 44 | 0.930 |
Why?
|
Capsaicin | 4 | 2016 | 231 | 0.860 |
Why?
|
Transient Receptor Potential Channels | 2 | 2023 | 130 | 0.840 |
Why?
|
Tooth Root | 5 | 2014 | 162 | 0.800 |
Why?
|
Nociceptors | 4 | 2016 | 461 | 0.780 |
Why?
|
Dental Pulp Diseases | 1 | 2021 | 12 | 0.780 |
Why?
|
Sensory Receptor Cells | 3 | 2023 | 513 | 0.730 |
Why?
|
Pain | 10 | 2023 | 5073 | 0.670 |
Why?
|
Neuropeptide Y | 4 | 2017 | 192 | 0.660 |
Why?
|
Thermosensing | 1 | 2018 | 55 | 0.620 |
Why?
|
Pain Measurement | 5 | 2020 | 3551 | 0.610 |
Why?
|
Hyperalgesia | 3 | 2020 | 532 | 0.610 |
Why?
|
Neuropeptides | 1 | 2023 | 944 | 0.590 |
Why?
|
Tooth, Nonvital | 2 | 2014 | 10 | 0.590 |
Why?
|
Neuroglia | 2 | 2021 | 956 | 0.590 |
Why?
|
TRPM Cation Channels | 1 | 2018 | 139 | 0.580 |
Why?
|
Activating Transcription Factor 3 | 1 | 2017 | 59 | 0.540 |
Why?
|
TRPV Cation Channels | 4 | 2016 | 244 | 0.530 |
Why?
|
Bacterial Infections | 1 | 2023 | 1391 | 0.490 |
Why?
|
Neurons, Afferent | 3 | 2023 | 498 | 0.420 |
Why?
|
Drinking Behavior | 1 | 2013 | 103 | 0.410 |
Why?
|
Dental Pulp Necrosis | 5 | 2021 | 22 | 0.400 |
Why?
|
Blogging | 1 | 2011 | 15 | 0.390 |
Why?
|
Immunity, Innate | 1 | 2023 | 3066 | 0.370 |
Why?
|
Dental Research | 1 | 2011 | 61 | 0.370 |
Why?
|
Neutrophils | 1 | 2023 | 3767 | 0.360 |
Why?
|
Periodontal Ligament | 1 | 2011 | 117 | 0.360 |
Why?
|
Lingual Nerve | 1 | 2010 | 31 | 0.350 |
Why?
|
Burning Mouth Syndrome | 1 | 2010 | 25 | 0.350 |
Why?
|
Clonazepam | 1 | 2010 | 135 | 0.340 |
Why?
|
Tooth Fractures | 5 | 2016 | 28 | 0.340 |
Why?
|
Calcitonin | 2 | 2021 | 329 | 0.330 |
Why?
|
Cold Temperature | 3 | 2019 | 785 | 0.330 |
Why?
|
Movement Disorders | 1 | 2013 | 459 | 0.320 |
Why?
|
Dental Pulp Test | 2 | 2021 | 5 | 0.320 |
Why?
|
Macrophages | 1 | 2023 | 5767 | 0.310 |
Why?
|
Cytokines | 2 | 2023 | 7396 | 0.310 |
Why?
|
Neuronal Plasticity | 1 | 2017 | 1436 | 0.300 |
Why?
|
Root Canal Preparation | 4 | 2014 | 25 | 0.290 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18255 | 0.270 |
Why?
|
Bradykinin | 1 | 2006 | 208 | 0.270 |
Why?
|
Hyperesthesia | 1 | 2006 | 23 | 0.270 |
Why?
|
Radiography, Dental | 2 | 2024 | 54 | 0.260 |
Why?
|
Receptors, Neuropeptide | 1 | 2006 | 106 | 0.260 |
Why?
|
Trigeminal Nerve | 1 | 2006 | 248 | 0.250 |
Why?
|
Radiography | 4 | 2024 | 6965 | 0.230 |
Why?
|
Dinoprostone | 1 | 2006 | 597 | 0.220 |
Why?
|
Arginine | 2 | 2006 | 934 | 0.220 |
Why?
|
Periapical Abscess | 2 | 2013 | 17 | 0.220 |
Why?
|
Gingival Crevicular Fluid | 1 | 2023 | 94 | 0.210 |
Why?
|
Nerve Block | 1 | 2010 | 706 | 0.210 |
Why?
|
Animals | 17 | 2023 | 168475 | 0.210 |
Why?
|
Information Dissemination | 1 | 2011 | 1126 | 0.210 |
Why?
|
Apicoectomy | 1 | 2022 | 23 | 0.210 |
Why?
|
Retreatment | 2 | 2022 | 598 | 0.210 |
Why?
|
Root Canal Filling Materials | 4 | 2014 | 29 | 0.200 |
Why?
|
Aluminum Compounds | 4 | 2014 | 55 | 0.200 |
Why?
|
Dentin | 4 | 2014 | 75 | 0.200 |
Why?
|
Calcium Compounds | 4 | 2014 | 38 | 0.200 |
Why?
|
Silicates | 4 | 2014 | 47 | 0.200 |
Why?
|
Neuralgia | 2 | 2019 | 615 | 0.190 |
Why?
|
Ganglia, Spinal | 1 | 2004 | 526 | 0.180 |
Why?
|
Feeding Behavior | 1 | 2013 | 3188 | 0.180 |
Why?
|
Population Surveillance | 1 | 2011 | 2598 | 0.180 |
Why?
|
Incisor | 3 | 2022 | 174 | 0.180 |
Why?
|
Oxides | 4 | 2014 | 401 | 0.170 |
Why?
|
Tooth Injuries | 1 | 2020 | 18 | 0.170 |
Why?
|
Cells, Cultured | 3 | 2021 | 18966 | 0.170 |
Why?
|
Acromegaly | 1 | 2023 | 310 | 0.170 |
Why?
|
Mice | 9 | 2023 | 81539 | 0.170 |
Why?
|
Toll-Like Receptor 4 | 1 | 2023 | 579 | 0.170 |
Why?
|
Rats, Sprague-Dawley | 5 | 2011 | 8181 | 0.170 |
Why?
|
Drug Combinations | 5 | 2024 | 2048 | 0.170 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2006 | 1252 | 0.160 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2021 | 222 | 0.160 |
Why?
|
Calcium Hydroxide | 2 | 2014 | 16 | 0.150 |
Why?
|
Male | 23 | 2024 | 360841 | 0.150 |
Why?
|
Stem Cells | 2 | 2021 | 3524 | 0.150 |
Why?
|
Interleukin-10 | 1 | 2023 | 1175 | 0.140 |
Why?
|
Neurons | 3 | 2023 | 9463 | 0.140 |
Why?
|
Mandibular Nerve | 1 | 2017 | 61 | 0.140 |
Why?
|
Analgesics | 1 | 2004 | 1070 | 0.140 |
Why?
|
Cohort Studies | 4 | 2024 | 41493 | 0.130 |
Why?
|
Minocycline | 2 | 2014 | 169 | 0.130 |
Why?
|
Metronidazole | 2 | 2014 | 232 | 0.130 |
Why?
|
Lipopolysaccharides | 1 | 2023 | 2206 | 0.130 |
Why?
|
Ciprofloxacin | 2 | 2014 | 312 | 0.130 |
Why?
|
Cartilage, Articular | 1 | 2023 | 1099 | 0.130 |
Why?
|
Dental Pulp Exposure | 1 | 2014 | 5 | 0.120 |
Why?
|
Periapical Tissue | 1 | 2014 | 10 | 0.120 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 22173 | 0.120 |
Why?
|
Female | 16 | 2024 | 392688 | 0.120 |
Why?
|
Tooth Bleaching | 1 | 2014 | 10 | 0.120 |
Why?
|
Tooth Discoloration | 1 | 2014 | 15 | 0.120 |
Why?
|
Rats | 5 | 2011 | 23741 | 0.120 |
Why?
|
Up-Regulation | 1 | 2023 | 4125 | 0.120 |
Why?
|
Tooth Avulsion | 1 | 2013 | 8 | 0.110 |
Why?
|
Monocytes | 1 | 2023 | 2570 | 0.110 |
Why?
|
Radiography, Bitewing | 1 | 2013 | 35 | 0.110 |
Why?
|
Tooth Replantation | 1 | 2013 | 10 | 0.110 |
Why?
|
Bicuspid | 1 | 2013 | 69 | 0.110 |
Why?
|
Humans | 26 | 2024 | 761578 | 0.110 |
Why?
|
Cell Differentiation | 2 | 2021 | 11530 | 0.110 |
Why?
|
Headache | 1 | 2021 | 1256 | 0.110 |
Why?
|
Flow Cytometry | 1 | 2023 | 5870 | 0.100 |
Why?
|
Indomethacin | 1 | 2013 | 325 | 0.100 |
Why?
|
Sucrose | 1 | 2013 | 158 | 0.100 |
Why?
|
Microglia | 1 | 2021 | 1362 | 0.100 |
Why?
|
Prospective Studies | 3 | 2024 | 54423 | 0.100 |
Why?
|
Internet | 1 | 2024 | 3093 | 0.100 |
Why?
|
Patient-Centered Care | 1 | 2021 | 1421 | 0.100 |
Why?
|
Blood Coagulation | 2 | 2014 | 1154 | 0.100 |
Why?
|
Stilbamidines | 1 | 2011 | 43 | 0.090 |
Why?
|
Child | 9 | 2024 | 80157 | 0.090 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26127 | 0.090 |
Why?
|
Treatment Outcome | 5 | 2024 | 64684 | 0.090 |
Why?
|
Sodium Hypochlorite | 2 | 2024 | 31 | 0.090 |
Why?
|
Nerve Growth Factor | 1 | 2011 | 158 | 0.090 |
Why?
|
Cell Survival | 1 | 2020 | 5791 | 0.090 |
Why?
|
Neovascularization, Physiologic | 2 | 2014 | 1349 | 0.090 |
Why?
|
Mice, Inbred BALB C | 2 | 2017 | 6214 | 0.090 |
Why?
|
Platelet-Rich Plasma | 1 | 2012 | 178 | 0.090 |
Why?
|
Skin | 2 | 2018 | 4484 | 0.080 |
Why?
|
Asia | 1 | 2011 | 619 | 0.080 |
Why?
|
Cachexia | 1 | 2011 | 202 | 0.080 |
Why?
|
Dental Pulp Cavity | 3 | 2013 | 35 | 0.080 |
Why?
|
Follow-Up Studies | 7 | 2014 | 39107 | 0.080 |
Why?
|
Oral Health | 1 | 2014 | 492 | 0.080 |
Why?
|
Anti-Bacterial Agents | 4 | 2014 | 7406 | 0.080 |
Why?
|
Neurogenic Inflammation | 1 | 2008 | 33 | 0.080 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2850 | 0.070 |
Why?
|
Inflammation | 3 | 2023 | 10774 | 0.070 |
Why?
|
Adolescent | 4 | 2024 | 88323 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2020 | 4415 | 0.070 |
Why?
|
Head and Neck Neoplasms | 1 | 2021 | 2895 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2020 | 10451 | 0.070 |
Why?
|
Mouth Neoplasms | 1 | 2011 | 596 | 0.070 |
Why?
|
Mechanotransduction, Cellular | 1 | 2011 | 529 | 0.060 |
Why?
|
Canada | 1 | 2011 | 2122 | 0.060 |
Why?
|
Radioimmunoassay | 1 | 2006 | 861 | 0.060 |
Why?
|
Behavior, Animal | 2 | 2020 | 1878 | 0.060 |
Why?
|
Recurrence | 2 | 2015 | 8466 | 0.060 |
Why?
|
Sensory Thresholds | 1 | 2006 | 377 | 0.060 |
Why?
|
Societies, Dental | 1 | 2024 | 33 | 0.060 |
Why?
|
Endodontics | 1 | 2024 | 20 | 0.060 |
Why?
|
Hot Temperature | 1 | 2011 | 1440 | 0.060 |
Why?
|
Zinc Oxide-Eugenol Cement | 2 | 2013 | 9 | 0.060 |
Why?
|
Methylmethacrylates | 2 | 2013 | 67 | 0.060 |
Why?
|
Cementogenesis | 2 | 2013 | 10 | 0.060 |
Why?
|
Dental Fistula | 2 | 2013 | 12 | 0.060 |
Why?
|
Receptors, Drug | 1 | 2004 | 157 | 0.060 |
Why?
|
Cross-Over Studies | 1 | 2010 | 2079 | 0.060 |
Why?
|
Root Canal Irrigants | 2 | 2013 | 15 | 0.060 |
Why?
|
Odontogenesis | 2 | 2013 | 65 | 0.050 |
Why?
|
Posterior Horn Cells | 1 | 2004 | 91 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2273 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2024 | 80646 | 0.050 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1903 | 0.050 |
Why?
|
In Situ Hybridization | 1 | 2006 | 1900 | 0.050 |
Why?
|
Peptide Fragments | 2 | 2006 | 5112 | 0.050 |
Why?
|
Exocytosis | 1 | 2004 | 320 | 0.050 |
Why?
|
Body Weight | 1 | 2013 | 4618 | 0.050 |
Why?
|
Middle Aged | 4 | 2022 | 220917 | 0.050 |
Why?
|
Drug Interactions | 1 | 2006 | 1416 | 0.050 |
Why?
|
Hypertrophy | 1 | 2023 | 561 | 0.050 |
Why?
|
Connective Tissue | 2 | 2013 | 419 | 0.050 |
Why?
|
Pilot Projects | 1 | 2014 | 8633 | 0.050 |
Why?
|
Growth Hormone | 1 | 2023 | 569 | 0.050 |
Why?
|
X-Ray Microtomography | 1 | 2023 | 456 | 0.040 |
Why?
|
Anticonvulsants | 1 | 2010 | 1906 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 1 | 2004 | 2468 | 0.040 |
Why?
|
Arthralgia | 1 | 2023 | 461 | 0.040 |
Why?
|
Time Factors | 2 | 2013 | 39970 | 0.040 |
Why?
|
Prevalence | 2 | 2014 | 15732 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2006 | 6228 | 0.040 |
Why?
|
Hedgehog Proteins | 1 | 2022 | 768 | 0.040 |
Why?
|
Cattle | 1 | 2023 | 3849 | 0.040 |
Why?
|
Comorbidity | 1 | 2011 | 10508 | 0.030 |
Why?
|
Adult | 4 | 2019 | 221200 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2010 | 12341 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2011 | 4026 | 0.030 |
Why?
|
Periapical Diseases | 1 | 2014 | 21 | 0.030 |
Why?
|
Specialties, Dental | 1 | 2014 | 35 | 0.030 |
Why?
|
General Practice, Dental | 1 | 2014 | 33 | 0.030 |
Why?
|
Odontometry | 1 | 2013 | 29 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10766 | 0.030 |
Why?
|
Dentin, Secondary | 1 | 2013 | 2 | 0.030 |
Why?
|
Tooth Crown | 1 | 2013 | 61 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11076 | 0.030 |
Why?
|
Dental Cementum | 1 | 2012 | 53 | 0.030 |
Why?
|
Calcification, Physiologic | 1 | 2013 | 170 | 0.030 |
Why?
|
Quality of Life | 1 | 2014 | 13367 | 0.030 |
Why?
|
Community-Based Participatory Research | 1 | 2014 | 221 | 0.030 |
Why?
|
Bone Matrix | 1 | 2012 | 120 | 0.030 |
Why?
|
Chlorhexidine | 1 | 2013 | 160 | 0.030 |
Why?
|
Young Adult | 2 | 2016 | 59254 | 0.020 |
Why?
|
New York | 1 | 2014 | 874 | 0.020 |
Why?
|
Receptor, PAR-2 | 1 | 2011 | 33 | 0.020 |
Why?
|
Tooth Extraction | 1 | 2012 | 229 | 0.020 |
Why?
|
Anti-Infective Agents, Local | 1 | 2013 | 247 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2023 | 9542 | 0.020 |
Why?
|
United States | 2 | 2024 | 72335 | 0.020 |
Why?
|
Blood | 1 | 2012 | 596 | 0.020 |
Why?
|
Biofilms | 1 | 2013 | 627 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3600 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2606 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2644 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2011 | 1085 | 0.020 |
Why?
|
Aged | 2 | 2016 | 169308 | 0.020 |
Why?
|
Mice, Nude | 1 | 2011 | 3614 | 0.010 |
Why?
|
Regeneration | 1 | 2013 | 1512 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9420 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2011 | 3605 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2013 | 5247 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15843 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11904 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36193 | 0.010 |
Why?
|
Weight Loss | 1 | 2011 | 2684 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9319 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2011 | 12794 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20099 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16990 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9177 | 0.010 |
Why?
|
Disease Progression | 1 | 2011 | 13510 | 0.010 |
Why?
|